Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, Benabid A L, Comoy J, Frerebeau P, Gilbert B, Houtteville J P, Jan M, Lapierre F, Loiseau H, Menei P, Mercier P, Moreau J J, Nivelon-Chevallier A, Parker F, Redondo A M, Scarabin J M, Tremoulet M, Zerah M, Maciazek J, Tournier-Lasserve E
INSERM E365, Faculté de Médecine Lariboisière, and Laboratoire de Cytogénetique, Hôpital Lariboisiere, Assistance Publique-Hôpitaux de Paris, Paris, France.
Am J Hum Genet. 2004 Feb;74(2):326-37. doi: 10.1086/381718. Epub 2004 Jan 22.
Cerebral cavernous malformations (CCM) are hamartomatous vascular malformations characterized by abnormally enlarged capillary cavities without intervening brain parenchyma. They cause seizures and focal neurological deficits due to cerebral hemorrhages. CCM loci have already been assigned to chromosomes 7q (CCM1), 7p (CCM2), and 3q (CCM3) and have been identified in 40%, 20%, and 40%, respectively, of families with CCM. Loss-of-function mutations have been identified in CCM1/KRIT1, the sole CCM gene identified to date. We report here the identification of MGC4607 as the CCM2 gene. We first reduced the size of the CCM2 interval from 22 cM to 7.5 cM by genetic linkage analysis. We then hypothesized that large deletions might be involved in the disorder, as already reported in other hamartomatous conditions, such as tuberous sclerosis or neurofibromatosis. We performed a high-density microsatellite genotyping of this 7.5-cM interval to search for putative null alleles in 30 unrelated families, and we identified, in 2 unrelated families, null alleles that were the result of deletions within a 350-kb interval flanked by markers D7S478 and D7S621. Additional microsatellite and single-nucleotide polymorphism genotyping showed that these two distinct deletions overlapped and that both of the two deleted the first exon of MGC4607, a known gene of unknown function. In both families, one of the two MGC4607 transcripts was not detected. We then identified eight additional point mutations within MGC4607 in eight of the remaining families. One of them led to the alteration of the initiation codon and five of them to a premature termination codon, including one nonsense, one frameshift, and three splice-site mutations. All these mutations cosegregated with the disease in the families and were not observed in 192 control chromosomes. MGC4607 is so far unrelated to any known gene family. Its implication in CCMs strongly suggests that it is a new player in vascular morphogenesis.
脑海绵状血管畸形(CCM)是错构瘤性血管畸形,其特征是毛细血管腔异常增大,其间无脑实质。它们因脑出血导致癫痫发作和局灶性神经功能缺损。CCM基因座已被定位于7号染色体长臂(CCM1)、7号染色体短臂(CCM2)和3号染色体长臂(CCM3),在CCM家族中分别有40%、20%和40%的家族被发现存在这些基因座。功能丧失性突变已在CCM1/KRIT1中被鉴定出来,这是迄今为止唯一被鉴定出的CCM基因。我们在此报告将MGC4607鉴定为CCM2基因。我们首先通过遗传连锁分析将CCM2基因区间的大小从22厘摩缩小到7.5厘摩。然后我们推测大的缺失可能与该疾病有关,正如在其他错构瘤性疾病中所报道的那样,如结节性硬化症或神经纤维瘤病。我们对这个7.5厘摩的区间进行了高密度微卫星基因分型,以在30个无亲缘关系的家族中寻找推定的无效等位基因,并且我们在2个无亲缘关系的家族中鉴定出了无效等位基因,这些无效等位基因是由位于标记D7S478和D7S621两侧的350千碱基区间内的缺失导致的。额外的微卫星和单核苷酸多态性基因分型表明,这两个不同的缺失区域重叠,并且二者都缺失了MGC4607的第一个外显子,MGC4607是一个功能未知的已知基因。在这两个家族中,未检测到MGC4607的两个转录本中的一个。然后我们在其余家族中的8个家族中,在MGC4607内又鉴定出了8个点突变。其中一个导致起始密码子改变,5个导致提前终止密码子,包括一个无义突变、一个移码突变和3个剪接位点突变。所有这些突变在家族中都与疾病共分离,并且在192条对照染色体中未观察到。到目前为止,MGC4607与任何已知基因家族都无关联。它在CCM中的作用强烈表明它是血管形态发生中的一个新因子。